The 2023-2028 Outlook for Human Microbiome Therapeutics for US Zip Codes
This study covers the latent demand outlook for human microbiome therapeutics across the states and zip codes of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 10,833 zip codes in the United States. For each zip code in question, the percent share the zip code is of its state and of the United States as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a zip code vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each state and zip code, latent demand estimates are created for human microbiome therapeutics. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.
In this report we define the sales of human microbiome therapeutics as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include 4D Pharma, AbbVie S.à.r.l., Accinov, ActoGeniX, Aju IB Investment, Ally Bridge Group, Amrita Therapeutics, AOBiome, AquaBounty Technologies, Arctic Aurora Life Science, Aspire Capital Fund, Assembly Biosciences, Azitra, Baseclear, BIOASTER, Biological & Popular Culture, Inc., BiomX, Bio-Technology General, Blue Turtle Bio, Bristol-Myers Squibb, BYTC Corporation, C3J Therapeutics, Caelus Health, Cd4 Biosciences, Inc., Cedars-Sinai Medical Centre, Chengdu Sen Nuo Wei Biotechnology Company, Ltd., CLI Ventures, Codexis Laboratories Hungary KFT, CoreBiome, Crestovo, CRS Bio, Inc., DayTwo, Digitalis Ventures, Effective Pharmaceuticals, Inc., Enterome, EnviroFlight, Epibiome, Epitope Pharmaceuticals, Inc., Evelo Biosciences, Evolve Biosystems, Ferring Pharmaceuticals, Finch Therapeutics, Genomatix, Ltd., Genten Therapeutics, Inc., GenVec, Global Bioscience Company, GT Biologics, Ltd., Hartlab, LLC, Harvest Capital Strategies, LLC, HealthMine, IBBL, iCarbonX, Igen Biotech Group, ImmuneBiotech AB, Immuron, INC Research, INRA Transfer, Intrexon, Janssen Biotech, Johnson & Johnson, Kallyope, Kolu Pohaku Management, LLC, Leading BioSciences, LNC Therapeutics, Lundbeckfond Ventures, MaaT Pharma SA, MATRISYS BIOSCIENCE, Mayo Clinic, Medistem, Medpace, Merck & Company, MICROBIOME THERAPEUTICS, Microbiomics, Ltd., Mirna Therapeutics, Nestle Health Science, Nitrocell, NIZO, Nubiyota, NuMe Health, LLC, Okanagan Specialty Fruits, Inc., Omnes Capital, Openbiome, Optibiotix Health, OrbiMed HealthCare Fund Management, Osel, OvaXon, LLC, Oxitec, Perceptive Advisors, Pfizer Venture Investments, Pharm-Olam International, Pipex Therapeutics, Inc., PRECIGEN, Prev AbR, LLC, ProDigest, Puretech Health, Putney Drug Corporation, Pylum Biosciences, Quorum Innovations, Rebiotix, Ritter Natural Sciences, LLC, Roche Venture Fund, Rock Springs Capital, S & I Ophthalmic, Second Genome, Seres Therapeutics, Seventure Partners, Shire, Solovax, Inc., SR One Venture Partners, Symberix, Symbiotic Health, Symbiotix Biotherapies, Synlogic, Synthetic Biologics, Takeda, TargEDys, Tech Coast Angels (TCA), The Microbiota Company, Ltd., Trans Ova Genetics LC, Tucana Health, Ltd., Vedanta Biosciences, Veristat, Vertex Pharmaceuticals, Whole Biome, and Xycrobe Therapeutics. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).
In this report we define the sales of human microbiome therapeutics as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include 4D Pharma, AbbVie S.à.r.l., Accinov, ActoGeniX, Aju IB Investment, Ally Bridge Group, Amrita Therapeutics, AOBiome, AquaBounty Technologies, Arctic Aurora Life Science, Aspire Capital Fund, Assembly Biosciences, Azitra, Baseclear, BIOASTER, Biological & Popular Culture, Inc., BiomX, Bio-Technology General, Blue Turtle Bio, Bristol-Myers Squibb, BYTC Corporation, C3J Therapeutics, Caelus Health, Cd4 Biosciences, Inc., Cedars-Sinai Medical Centre, Chengdu Sen Nuo Wei Biotechnology Company, Ltd., CLI Ventures, Codexis Laboratories Hungary KFT, CoreBiome, Crestovo, CRS Bio, Inc., DayTwo, Digitalis Ventures, Effective Pharmaceuticals, Inc., Enterome, EnviroFlight, Epibiome, Epitope Pharmaceuticals, Inc., Evelo Biosciences, Evolve Biosystems, Ferring Pharmaceuticals, Finch Therapeutics, Genomatix, Ltd., Genten Therapeutics, Inc., GenVec, Global Bioscience Company, GT Biologics, Ltd., Hartlab, LLC, Harvest Capital Strategies, LLC, HealthMine, IBBL, iCarbonX, Igen Biotech Group, ImmuneBiotech AB, Immuron, INC Research, INRA Transfer, Intrexon, Janssen Biotech, Johnson & Johnson, Kallyope, Kolu Pohaku Management, LLC, Leading BioSciences, LNC Therapeutics, Lundbeckfond Ventures, MaaT Pharma SA, MATRISYS BIOSCIENCE, Mayo Clinic, Medistem, Medpace, Merck & Company, MICROBIOME THERAPEUTICS, Microbiomics, Ltd., Mirna Therapeutics, Nestle Health Science, Nitrocell, NIZO, Nubiyota, NuMe Health, LLC, Okanagan Specialty Fruits, Inc., Omnes Capital, Openbiome, Optibiotix Health, OrbiMed HealthCare Fund Management, Osel, OvaXon, LLC, Oxitec, Perceptive Advisors, Pfizer Venture Investments, Pharm-Olam International, Pipex Therapeutics, Inc., PRECIGEN, Prev AbR, LLC, ProDigest, Puretech Health, Putney Drug Corporation, Pylum Biosciences, Quorum Innovations, Rebiotix, Ritter Natural Sciences, LLC, Roche Venture Fund, Rock Springs Capital, S & I Ophthalmic, Second Genome, Seres Therapeutics, Seventure Partners, Shire, Solovax, Inc., SR One Venture Partners, Symberix, Symbiotic Health, Symbiotix Biotherapies, Synlogic, Synthetic Biologics, Takeda, TargEDys, Tech Coast Angels (TCA), The Microbiota Company, Ltd., Trans Ova Genetics LC, Tucana Health, Ltd., Vedanta Biosciences, Veristat, Vertex Pharmaceuticals, Whole Biome, and Xycrobe Therapeutics. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).
1 INTRODUCTION
1.1 OVERVIEW
1.2 WHAT IS LATENT DEMAND AND THE P.I.E.?
1.3 THE METHODOLOGY
1.3.1 STEP 1. PRODUCT DEFINITION AND DATA COLLECTION
1.3.2 STEP 2. FILTERING AND SMOOTHING
1.3.3 STEP 3. FILLING IN MISSING VALUES
1.3.4 STEP 4. VARYING PARAMETER, NON-LINEAR ESTIMATION
1.3.5 STEP 5. FIXED-PARAMETER LINEAR ESTIMATION
1.3.6 STEP 6. AGGREGATION AND BENCHMARKING
1.4 FREQUENTLY ASKED QUESTIONS (FAQ)
1.4.1 CATEGORY DEFINITION
1.4.2 UNITS
1.4.3 METHODOLOGY
2 SUMMARY OF FINDINGS
2.1 LATENT DEMAND IN THE UNITED STATES
2.2 LATENT DEMAND BY YEAR IN THE UNITED STATES
2.3 TOP 100 CITIES IN THE UNITED STATES
3 FAR WEST
3.1 EXECUTIVE SUMMARY
3.2 LATENT DEMAND BY YEAR - ALASKA
3.3 CITIES SORTED BY ZIPCODE - ALASKA
3.4 LATENT DEMAND BY YEAR - CALIFORNIA
3.5 CITIES SORTED BY ZIPCODE - CALIFORNIA
3.6 LATENT DEMAND BY YEAR - HAWAII
3.7 CITIES SORTED BY ZIPCODE - HAWAII
3.8 LATENT DEMAND BY YEAR - NEVADA
3.9 CITIES SORTED BY ZIPCODE - NEVADA
3.10 LATENT DEMAND BY YEAR - OREGON
3.11 CITIES SORTED BY ZIPCODE - OREGON
3.12 LATENT DEMAND BY YEAR - WASHINGTON
3.13 CITIES SORTED BY ZIPCODE - WASHINGTON
4 GREAT LAKES
4.1 EXECUTIVE SUMMARY
4.2 LATENT DEMAND BY YEAR - ILLINOIS
4.3 CITIES SORTED BY ZIPCODE - ILLINOIS
4.4 LATENT DEMAND BY YEAR - INDIANA
4.5 CITIES SORTED BY ZIPCODE - INDIANA
4.6 LATENT DEMAND BY YEAR - MICHIGAN
4.7 CITIES SORTED BY ZIPCODE - MICHIGAN
4.8 LATENT DEMAND BY YEAR - OHIO
4.9 CITIES SORTED BY ZIPCODE - OHIO
4.10 LATENT DEMAND BY YEAR - WISCONSIN
4.11 CITIES SORTED BY ZIPCODE - WISCONSIN
5 MID-ATLANTIC
5.1 EXECUTIVE SUMMARY
5.2 LATENT DEMAND BY YEAR - DELAWARE
5.3 CITIES SORTED BY ZIPCODE - DELAWARE
5.4 LATENT DEMAND BY YEAR - DISTRICT OF COLUMBIA
5.5 CITIES SORTED BY ZIPCODE - DISTRICT OF COLUMBIA
5.6 LATENT DEMAND BY YEAR - MARYLAND
5.7 CITIES SORTED BY ZIPCODE - MARYLAND
5.8 LATENT DEMAND BY YEAR - NEW JERSEY
5.9 CITIES SORTED BY ZIPCODE - NEW JERSEY
5.10 LATENT DEMAND BY YEAR - NEW YORK
5.11 CITIES SORTED BY ZIPCODE - NEW YORK
5.12 LATENT DEMAND BY YEAR - PENNSYLVANIA
5.13 CITIES SORTED BY ZIPCODE - PENNSYLVANIA
6 NEW ENGLAND
6.1 EXECUTIVE SUMMARY
6.2 LATENT DEMAND BY YEAR - CONNECTICUT
6.3 CITIES SORTED BY ZIPCODE - CONNECTICUT
6.4 LATENT DEMAND BY YEAR - MAINE
6.5 CITIES SORTED BY ZIPCODE - MAINE
6.6 LATENT DEMAND BY YEAR - MASSACHUSETTS
6.7 CITIES SORTED BY ZIPCODE - MASSACHUSETTS
6.8 LATENT DEMAND BY YEAR - NEW HAMPSHIRE
6.9 CITIES SORTED BY ZIPCODE - NEW HAMPSHIRE
6.10 LATENT DEMAND BY YEAR - RHODE ISLAND
6.11 CITIES SORTED BY ZIPCODE - RHODE ISLAND
6.12 LATENT DEMAND BY YEAR - VERMONT
6.13 CITIES SORTED BY ZIPCODE - VERMONT
7 PLAINS
7.1 EXECUTIVE SUMMARY
7.2 LATENT DEMAND BY YEAR - IOWA
7.3 CITIES SORTED BY ZIPCODE - IOWA
7.4 LATENT DEMAND BY YEAR - KANSAS
7.5 CITIES SORTED BY ZIPCODE - KANSAS
7.6 LATENT DEMAND BY YEAR - MINNESOTA
7.7 CITIES SORTED BY ZIPCODE - MINNESOTA
7.8 LATENT DEMAND BY YEAR - MISSOURI
7.9 CITIES SORTED BY ZIPCODE - MISSOURI
7.10 LATENT DEMAND BY YEAR - NEBRASKA
7.11 CITIES SORTED BY ZIPCODE - NEBRASKA
7.12 LATENT DEMAND BY YEAR - NORTH DAKOTA
7.13 CITIES SORTED BY ZIPCODE - NORTH DAKOTA
7.14 LATENT DEMAND BY YEAR - SOUTH DAKOTA
7.15 CITIES SORTED BY ZIPCODE - SOUTH DAKOTA
8 ROCKIES
8.1 EXECUTIVE SUMMARY
8.2 LATENT DEMAND BY YEAR - COLORADO
8.3 CITIES SORTED BY ZIPCODE - COLORADO
8.4 LATENT DEMAND BY YEAR - IDAHO
8.5 CITIES SORTED BY ZIPCODE - IDAHO
8.6 LATENT DEMAND BY YEAR - MONTANA
8.7 CITIES SORTED BY ZIPCODE - MONTANA
8.8 LATENT DEMAND BY YEAR - UTAH
8.9 CITIES SORTED BY ZIPCODE - UTAH
8.10 LATENT DEMAND BY YEAR - WYOMING
8.11 CITIES SORTED BY ZIPCODE - WYOMING
9 SOUTHEAST
9.1 EXECUTIVE SUMMARY
9.2 LATENT DEMAND BY YEAR - ALABAMA
9.3 CITIES SORTED BY ZIPCODE - ALABAMA
9.4 LATENT DEMAND BY YEAR - ARKANSAS
9.5 CITIES SORTED BY ZIPCODE - ARKANSAS
9.6 LATENT DEMAND BY YEAR - FLORIDA
9.7 CITIES SORTED BY ZIPCODE - FLORIDA
9.8 LATENT DEMAND BY YEAR - GEORGIA
9.9 CITIES SORTED BY ZIPCODE - GEORGIA
9.10 LATENT DEMAND BY YEAR - KENTUCKY
9.11 CITIES SORTED BY ZIPCODE - KENTUCKY
9.12 LATENT DEMAND BY YEAR - LOUISIANA
9.13 CITIES SORTED BY ZIPCODE - LOUISIANA
9.14 LATENT DEMAND BY YEAR - MISSISSIPPI
9.15 CITIES SORTED BY ZIPCODE - MISSISSIPPI
9.16 LATENT DEMAND BY YEAR - NORTH CAROLINA
9.17 CITIES SORTED BY ZIPCODE - NORTH CAROLINA
9.18 LATENT DEMAND BY YEAR - SOUTH CAROLINA
9.19 CITIES SORTED BY ZIPCODE - SOUTH CAROLINA
9.20 LATENT DEMAND BY YEAR - TENNESSEE
9.21 CITIES SORTED BY ZIPCODE - TENNESSEE
9.22 LATENT DEMAND BY YEAR - VIRGINIA
9.23 CITIES SORTED BY ZIPCODE - VIRGINIA
9.24 LATENT DEMAND BY YEAR - WEST VIRGINIA
9.25 CITIES SORTED BY ZIPCODE - WEST VIRGINIA
10 SOUTHWEST
10.1 EXECUTIVE SUMMARY
10.2 LATENT DEMAND BY YEAR - ARIZONA
10.3 CITIES SORTED BY ZIPCODE - ARIZONA
10.4 LATENT DEMAND BY YEAR - NEW MEXICO
10.5 CITIES SORTED BY ZIPCODE - NEW MEXICO
10.6 LATENT DEMAND BY YEAR - OKLAHOMA
10.7 CITIES SORTED BY ZIPCODE - OKLAHOMA
10.8 LATENT DEMAND BY YEAR - TEXAS
10.9 CITIES SORTED BY ZIPCODE - TEXAS
11 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS
11.1 DISCLAIMERS & SAFE HARBOR
11.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS
1.1 OVERVIEW
1.2 WHAT IS LATENT DEMAND AND THE P.I.E.?
1.3 THE METHODOLOGY
1.3.1 STEP 1. PRODUCT DEFINITION AND DATA COLLECTION
1.3.2 STEP 2. FILTERING AND SMOOTHING
1.3.3 STEP 3. FILLING IN MISSING VALUES
1.3.4 STEP 4. VARYING PARAMETER, NON-LINEAR ESTIMATION
1.3.5 STEP 5. FIXED-PARAMETER LINEAR ESTIMATION
1.3.6 STEP 6. AGGREGATION AND BENCHMARKING
1.4 FREQUENTLY ASKED QUESTIONS (FAQ)
1.4.1 CATEGORY DEFINITION
1.4.2 UNITS
1.4.3 METHODOLOGY
2 SUMMARY OF FINDINGS
2.1 LATENT DEMAND IN THE UNITED STATES
2.2 LATENT DEMAND BY YEAR IN THE UNITED STATES
2.3 TOP 100 CITIES IN THE UNITED STATES
3 FAR WEST
3.1 EXECUTIVE SUMMARY
3.2 LATENT DEMAND BY YEAR - ALASKA
3.3 CITIES SORTED BY ZIPCODE - ALASKA
3.4 LATENT DEMAND BY YEAR - CALIFORNIA
3.5 CITIES SORTED BY ZIPCODE - CALIFORNIA
3.6 LATENT DEMAND BY YEAR - HAWAII
3.7 CITIES SORTED BY ZIPCODE - HAWAII
3.8 LATENT DEMAND BY YEAR - NEVADA
3.9 CITIES SORTED BY ZIPCODE - NEVADA
3.10 LATENT DEMAND BY YEAR - OREGON
3.11 CITIES SORTED BY ZIPCODE - OREGON
3.12 LATENT DEMAND BY YEAR - WASHINGTON
3.13 CITIES SORTED BY ZIPCODE - WASHINGTON
4 GREAT LAKES
4.1 EXECUTIVE SUMMARY
4.2 LATENT DEMAND BY YEAR - ILLINOIS
4.3 CITIES SORTED BY ZIPCODE - ILLINOIS
4.4 LATENT DEMAND BY YEAR - INDIANA
4.5 CITIES SORTED BY ZIPCODE - INDIANA
4.6 LATENT DEMAND BY YEAR - MICHIGAN
4.7 CITIES SORTED BY ZIPCODE - MICHIGAN
4.8 LATENT DEMAND BY YEAR - OHIO
4.9 CITIES SORTED BY ZIPCODE - OHIO
4.10 LATENT DEMAND BY YEAR - WISCONSIN
4.11 CITIES SORTED BY ZIPCODE - WISCONSIN
5 MID-ATLANTIC
5.1 EXECUTIVE SUMMARY
5.2 LATENT DEMAND BY YEAR - DELAWARE
5.3 CITIES SORTED BY ZIPCODE - DELAWARE
5.4 LATENT DEMAND BY YEAR - DISTRICT OF COLUMBIA
5.5 CITIES SORTED BY ZIPCODE - DISTRICT OF COLUMBIA
5.6 LATENT DEMAND BY YEAR - MARYLAND
5.7 CITIES SORTED BY ZIPCODE - MARYLAND
5.8 LATENT DEMAND BY YEAR - NEW JERSEY
5.9 CITIES SORTED BY ZIPCODE - NEW JERSEY
5.10 LATENT DEMAND BY YEAR - NEW YORK
5.11 CITIES SORTED BY ZIPCODE - NEW YORK
5.12 LATENT DEMAND BY YEAR - PENNSYLVANIA
5.13 CITIES SORTED BY ZIPCODE - PENNSYLVANIA
6 NEW ENGLAND
6.1 EXECUTIVE SUMMARY
6.2 LATENT DEMAND BY YEAR - CONNECTICUT
6.3 CITIES SORTED BY ZIPCODE - CONNECTICUT
6.4 LATENT DEMAND BY YEAR - MAINE
6.5 CITIES SORTED BY ZIPCODE - MAINE
6.6 LATENT DEMAND BY YEAR - MASSACHUSETTS
6.7 CITIES SORTED BY ZIPCODE - MASSACHUSETTS
6.8 LATENT DEMAND BY YEAR - NEW HAMPSHIRE
6.9 CITIES SORTED BY ZIPCODE - NEW HAMPSHIRE
6.10 LATENT DEMAND BY YEAR - RHODE ISLAND
6.11 CITIES SORTED BY ZIPCODE - RHODE ISLAND
6.12 LATENT DEMAND BY YEAR - VERMONT
6.13 CITIES SORTED BY ZIPCODE - VERMONT
7 PLAINS
7.1 EXECUTIVE SUMMARY
7.2 LATENT DEMAND BY YEAR - IOWA
7.3 CITIES SORTED BY ZIPCODE - IOWA
7.4 LATENT DEMAND BY YEAR - KANSAS
7.5 CITIES SORTED BY ZIPCODE - KANSAS
7.6 LATENT DEMAND BY YEAR - MINNESOTA
7.7 CITIES SORTED BY ZIPCODE - MINNESOTA
7.8 LATENT DEMAND BY YEAR - MISSOURI
7.9 CITIES SORTED BY ZIPCODE - MISSOURI
7.10 LATENT DEMAND BY YEAR - NEBRASKA
7.11 CITIES SORTED BY ZIPCODE - NEBRASKA
7.12 LATENT DEMAND BY YEAR - NORTH DAKOTA
7.13 CITIES SORTED BY ZIPCODE - NORTH DAKOTA
7.14 LATENT DEMAND BY YEAR - SOUTH DAKOTA
7.15 CITIES SORTED BY ZIPCODE - SOUTH DAKOTA
8 ROCKIES
8.1 EXECUTIVE SUMMARY
8.2 LATENT DEMAND BY YEAR - COLORADO
8.3 CITIES SORTED BY ZIPCODE - COLORADO
8.4 LATENT DEMAND BY YEAR - IDAHO
8.5 CITIES SORTED BY ZIPCODE - IDAHO
8.6 LATENT DEMAND BY YEAR - MONTANA
8.7 CITIES SORTED BY ZIPCODE - MONTANA
8.8 LATENT DEMAND BY YEAR - UTAH
8.9 CITIES SORTED BY ZIPCODE - UTAH
8.10 LATENT DEMAND BY YEAR - WYOMING
8.11 CITIES SORTED BY ZIPCODE - WYOMING
9 SOUTHEAST
9.1 EXECUTIVE SUMMARY
9.2 LATENT DEMAND BY YEAR - ALABAMA
9.3 CITIES SORTED BY ZIPCODE - ALABAMA
9.4 LATENT DEMAND BY YEAR - ARKANSAS
9.5 CITIES SORTED BY ZIPCODE - ARKANSAS
9.6 LATENT DEMAND BY YEAR - FLORIDA
9.7 CITIES SORTED BY ZIPCODE - FLORIDA
9.8 LATENT DEMAND BY YEAR - GEORGIA
9.9 CITIES SORTED BY ZIPCODE - GEORGIA
9.10 LATENT DEMAND BY YEAR - KENTUCKY
9.11 CITIES SORTED BY ZIPCODE - KENTUCKY
9.12 LATENT DEMAND BY YEAR - LOUISIANA
9.13 CITIES SORTED BY ZIPCODE - LOUISIANA
9.14 LATENT DEMAND BY YEAR - MISSISSIPPI
9.15 CITIES SORTED BY ZIPCODE - MISSISSIPPI
9.16 LATENT DEMAND BY YEAR - NORTH CAROLINA
9.17 CITIES SORTED BY ZIPCODE - NORTH CAROLINA
9.18 LATENT DEMAND BY YEAR - SOUTH CAROLINA
9.19 CITIES SORTED BY ZIPCODE - SOUTH CAROLINA
9.20 LATENT DEMAND BY YEAR - TENNESSEE
9.21 CITIES SORTED BY ZIPCODE - TENNESSEE
9.22 LATENT DEMAND BY YEAR - VIRGINIA
9.23 CITIES SORTED BY ZIPCODE - VIRGINIA
9.24 LATENT DEMAND BY YEAR - WEST VIRGINIA
9.25 CITIES SORTED BY ZIPCODE - WEST VIRGINIA
10 SOUTHWEST
10.1 EXECUTIVE SUMMARY
10.2 LATENT DEMAND BY YEAR - ARIZONA
10.3 CITIES SORTED BY ZIPCODE - ARIZONA
10.4 LATENT DEMAND BY YEAR - NEW MEXICO
10.5 CITIES SORTED BY ZIPCODE - NEW MEXICO
10.6 LATENT DEMAND BY YEAR - OKLAHOMA
10.7 CITIES SORTED BY ZIPCODE - OKLAHOMA
10.8 LATENT DEMAND BY YEAR - TEXAS
10.9 CITIES SORTED BY ZIPCODE - TEXAS
11 DISCLAIMERS, WARRANTIES, AND USER AGREEMENT PROVISIONS
11.1 DISCLAIMERS & SAFE HARBOR
11.2 ICON GROUP INTERNATIONAL, INC. USER AGREEMENT PROVISIONS
